Author:
Braithwaite Tasanee,Nanji Afshan A,Greenberg Paul B
Reference96 articles.
1. Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study;Brown;Ophthalmology,2010
2. Pegaptanib sodium for macular edema secondary to central retinal vein occlusion;Wroblewski;Archives of Ophthalmology,2009
3. Prolongation of activity of single intravitreal bevacizumab by adjuvant topical aqueous depressant (Timolol-Dorzolamide);Byeon;Graefe's Archive for Clinical and Experimental Ophthalmology,2009
4. A randomized study comparing ranibizumab to sham in patients with macular edema secondary to CRVO Ongoing study
5. Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion (BRAVO) Ongoing study
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献